The Latest Breaking News from Ovarian Cancer

Pfizer (NYSE:PFE) announced positive top-line results from the pivotal Phase 3 trial assessing the safety, tolerability, and immunogenicity of its investigational pentavalent meningococcal vaccine (MenABCWY) in healthy individuals 10 through 25 years of age. The trial met all primary and secondary endpoints. Pfizer shares traded in a range of $45.7…

Shelley O’Keefe gets emotional talking about what last year’s qualifier did for her mentally.

Chris Evert on having ovarian cancer, Emma Raducanu’s chances of more glory, the future of women’s tennis and who is the greatest

Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy candidate for solid tumor cancers, were published today in Nature Medicine. The initial results from the study are expected during second half of 2023. Gritstone shares traded in a range of $3.96 to $4.24…

Jane Harriss says a full-time surgical service for gynaecological cancers is "wonderful" for Canberra women who are currently receiving treatment and for those who potentially might be diagnosed with the disease in the future.

A team of doctors and scientists in NHS Tayside and the University of Dundee has uncovered important new information about how ovarian cancer cells become resistant

Martine Peel says she is trying 'everything' to stay as well for as long as possible after devastating cancer diagnosis

Rachel Stephen-Smith has said discussions to establish a centre are a priority.

Gillian McLaren composed the artwork of NHS staff who looked after during the pandemic.

A mum-of-two has warned women of the symptoms of a 'silent killer' after her irregular periods led her to believe she was going through the menopause - but it turned out to be ovarian cancer

The disease is known as the 'silent killer'